Search by Drug Name or NDC

    NDC 70710-1839-01 Nelarabine 5 mg/mL Details

    Nelarabine 5 mg/mL

    Nelarabine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is NELARABINE.

    Product Information

    NDC 70710-1839
    Product ID 70710-1839_7b0a1790-c6e3-4f09-859f-1ae9db46b007
    Associated GPIs
    GCN Sequence Number 059981
    GCN Sequence Number Description nelarabine VIAL 250MG/50ML INTRAVEN
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 25932
    HICL Sequence Number 033304
    HICL Sequence Number Description NELARABINE
    Brand/Generic Generic
    Proprietary Name Nelarabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Nelarabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 5
    Active Ingredient Units mg/mL
    Substance Name NELARABINE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215037
    Listing Certified Through 2024-12-31

    Package

    NDC 70710-1839-01 (70710183901)

    NDC Package Code 70710-1839-1
    Billing NDC 70710183901
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1839-1) / 50 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2022-06-24
    NDC Exclude Flag N
    Pricing Information N/A